|
Marsal-Beltran A, Rodriguez-Castellano A, Astiarraga B, Calvo E, Rada P, Madeira A, Rodriguez-Pena MM, Llaurado G, Nunez-Roa C, Gomez-Santos B, Maymo-Masip E, Bosch R, Frutos MD, Moreno-Navarrete JM, Ramos-Molina B, Aspichueta P, Joven J, Fernandez-Real JM, Quer JC, Valverde AM, Pardo A, Vendrell J, Ceperuelo-Mallafre V, Fernandez-Veledo S. Protective effects of the succinate/SUCNR1 axis on damaged hepatocytes in NAFLD. Metabolism. 2023 Aug;145:155630. doi: 10.1016/j.metabol.2023.155630. Epub 2023 Jun 13. PubMed PMID: 37315889.
AÑO: 2023; IF: 10.8
|
37315889
|
Nunez-Sanchez MA, Martinez-Sanchez MA, Martinez-Montoro JI, Balaguer-Roman A, Murcia-Garcia E, Fernandez-Ruiz VE, Ferrer-Gomez M, Martinez-Caceres CM, Sledzinski T, Frutos MD, Hernandez-Morante JJ, Fernandez-Garcia JC, Queipo-Ortuno MI, Ruiz-Alcaraz AJ, Mika A, Ramos-Molina B. Lipidomic Analysis Reveals Alterations in Hepatic FA Profile Associated With MASLD Stage in Patients With Obesity. J Clin Endocrinol Metab. 2024 Jun 17;109(7):1781-1792. doi: 10.1210/clinem/dgae028. PubMed PMID: 38217869.
AÑO: 2024; IF: 5.0
|
|
Colosimo S, Martinez-Sanchez MA, Balaguer-Roman A, Fernandez-Ruiz VE, Nunez-Sanchez MA, Ferrer-Gomez M, Frutos MD, Tomlinson JW, Bertoli S, Marchesini G, Ramos-Molina B. A novel model for predicting diabetes remission after bariatric surgery based on the measurement of C-peptide and creatinine in serum: A pilot study. Nutr Metab Cardiovasc Dis. 2024 May;34(5):1142-1145. doi: 10.1016/j.numecd.2023.12.008. Epub 2023 Dec 16. PubMed PMID: 38220504.
AÑO: 2024; IF: 3.3
|
|
Castellano-Castillo D, Nunez-Sanchez MA, Balaguer-Roman A, Martinez-Sanchez MA, Fernandez-Ruiz VE, Ferrer-Gomez M, Martinez CM, Frutos MD, Queipo-Ortuno MI, Cardona F, Ramos-Molina B. The role of PCSK9 in metabolic dysfunction-associated steatotic liver disease and its impact on bariatric surgery outcomes. Surg Obes Relat Dis. 2024 Jul;20(7):652-659. doi: 10.1016/j.soard.2024.01.017. Epub 2024 Feb 6. PubMed PMID: 38490825.
AÑO: 2024; IF: 3.5
|
|
Castellano-Castillo D, Ramos-Molina B, Frutos MD, Arranz-Salas I, Reyes-Engel A, Queipo-Ortuno MI, Cardona F. RNA expression changes driven by altered epigenetics status related to NASH etiology. Biomed Pharmacother. 2024 May;174:116508. doi: 10.1016/j.biopha.2024.116508. Epub 2024 Apr 4. PubMed PMID: 38579398.
AÑO: 2024; IF: 6.9
|